Skip to main content
. 2022 Jun 24;13(3):100583. doi: 10.1016/j.jaim.2022.100583

Table 2.

Effect of the drug GTG on serum lipids, blood glucose, and serum VCAM-1 on dyslipidemia induced in Wistar rats.

Test parameter BT AT
TC (mg/dL) 156.33 ± 39.42 71.00 ± 11.12#
TG (mg/dL) 202 ± 81.61 92 ± 40.85∗
HDL (mg/dL) 94.16 ± 22.78 71.50 ± 51.39
LDL (mg/dL) 42.73 ± 27.59 42.80 ± 32.51
VLDL (mg/dL) 40.43 ± 16.32 18.43 ± 8.17∗
Blood glucose (mg/dL) 137 ± 20.73 53.66 ± 18.15#
VCAM 1 (ng/mL) 8.25 ± 1.02 4.14 ± 0.96#

BT = before treatment, AT = after treatment.

∗ = P < 0.05, # = P < 0.005 compared to before treatment in dyslipidemic group.

Values are expressed in mean ± SD.